Remove Academic Remove Biomarkers Remove Cancer
article thumbnail

ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

DAIC

The PROACT study reported no impact on cardiotoxicity biomarkers or secondary endpoints related to heart function among patients who took high doses of enalapril, an ACE inhibitor, along with high doses of anthracyclines. Anthracyclines are a well-established class of cancer drugs that are used to treat several types of cancer.

article thumbnail

Rise of the Lysenkoist Cardiologists

Dr. Anish Koka

It would be like diagnosing women with metastatic breast cancer, but finding that just as many women with metastatic breast cancer were alive in 5 years as women not diagnosed with breast cancer. If women have more MINOCA, but the diagnosis doesn’t lead to a worse prognosis… who cares? ” What is going on?

article thumbnail

Championing Change: Celebrating Cardiometabolic Health Congress (CMHC) Women Faculty

Cardiometabolic Health Congress

Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases. Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society.